Resona Asset Management Co.,Ltd.

Position in EXEL — Exelixis, Inc.

CIK 1944142 KOTO-KU,TOKYO, M0

Position in EXEL

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$2,099,899

+$329,486 QoQ

Shares Held

38,594

-6.5% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#261

of 751 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Resona Asset Management Co.,Ltd. holds $108,055,256 across 14 Biotechnology names. EXEL ranks #8 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	84,092	$41,771,019
2	REGN	Regeneron Pharmaceuticals, Inc.	30,289	$18,886,403
3	ALNY	Alnylam Pharmaceuticals, Inc.	40,053	$12,057,154
4	INCY	Incyte Corp	78,119	$8,855,569
5	RVMD	Revolution Medicines, Inc.	43,260	$8,101,732
6	RPRX	Royalty Pharma plc	109,991	$6,167,195
7	INSM	INSMED Inc	56,132	$5,984,793
8	EXEL	Exelixis, Inc. This page	38,594	$2,099,899

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,099,899	38,594	-6.5%	Shares	Other	2026-07-29
2026-03-31	$1,770,413	41,278	0.0%	Shares	Other	2026-04-30
2025-12-31	$1,809,214	41,278	-10.9%	Shares	Other	2026-02-06
2025-09-30	$1,914,089	46,346	-2.7%	Shares	Other	2025-10-31
2025-06-30	$2,099,221	47,623	+1.8%	Shares	Other	2025-08-06
2025-03-31	$1,727,782	46,798	0.0%	Shares	Other	2025-05-13
2024-12-31	$1,558,373	46,798	-1.6%	Shares	Other	2025-02-13
2024-09-30	$1,234,389	47,568	0.0%	Shares	Other	2025-02-20
2024-06-30	$1,068,852	47,568	+8.8%	Shares	Other	2025-02-20
2024-03-31	$1,037,689	43,729	—	Shares	Other	2025-02-20
No filing history on record for this holder in this stock.